The first annual International Congress on the Future of Neurology convenes in New York City in September. Which thought leaders will be moderating?
Stephen Silberstein, MD
Fred Rincon, MD, MSc
Karl Doghramji, MD
Discovery and application of novel therapeutics for devastating disease is perhaps nowhere as critical as in clinical neurology. In September, in New York City, the first annual International Congress on the Future of Neurology will convene a unique group of world leaders in research and clinical practice to present new data and stimulate discussion on topics that span the discipline of neurology.
The 2-day Congress, chaired by Stephen D. Silberstein, MD, professor of neurology and director of the Jefferson Headache Center in Philadelphia, will be held September 27-29, 2019, and focus on therapeutic developments and clinical decision making in 8 areas of neurologic disease: stroke, headache/migraine, epilepsy, movement disorders, neuromuscular disorders, multiple sclerosis, and dementia/Alzheimer disease.
Faculty representing leading academic medical centers in the US and Europe will moderate panel presentations, question and answer sessions, case studies, and other interactive formats designed to open dialogue on emerging therapies as well as encourage sharing of best practices across specific therapeutic areas.
Among the 8 thought leaders scheduled to present at the meeting in September are Fred Rincon, MD, MSc, and Karl Doghramji, MD, both of Thomas Jefferson Univerity in Philadelphia, Penn.
Fred Rincon, MD, MSc, division head of cerebrovascular disease at the Vicki and Jack Farber Institute for Neuroscience and associate professor of neurology and neurological surgery at Thomas Jefferson University, will moderate a session on stroke, titled "Novel Interventions in Stroke Care," where stroke experts will discuss limitations to current pharmacologic and surgical interventions; how to extend the treatment window for acute ischemic stroke; and promising therapeutic approaches for hemorrhagic stroke.
Karl Doghramji, MD, professor of psychiatry, neurology, and medicine at Thomas Jefferson University, Medical Director, Jefferson Sleep Disorders Center, and Program Director, Fellowship in Sleep Medicine, will moderate the sleep disorders session, titled "Beyond Counting Sheep: Effective Therapies for Sleep Disorders." Topics covered will include new therapeutic approaches to insomnia; effective management of narcolepsy, including risks for therapeutic abuse; and, physiologic versus pharmacologic interventions for excessive daytime sleepiness and obstructive sleep apnea.
Moderators currently planned for the other 6 sessions: Alzheimer/dementia, Richard S. Isaacson, MD; Epilepsy, Elizabeth A. Thiele, MD, PhD; neuromuscular disease, Claudia A. Chiriboga, MD, MPH; multiple sclerosis, Thomas Leist, MD, PhD; movement disorders, Jeffrey B. Ratliff, MD; migraine, William Young, MD.
The full agenda for the 2 days is available here. For more information and to register, click here. Receive 25% off registration fees with code Neuro19SI.